|Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer|
K Kozaki, I Imoto, S Mogi, K Omura, J Inazawa
Cancer research 68 (7), 2094-2105, 2008
|miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma|
M Furuta, K Kozaki, S Tanaka, S Arii, I Imoto, J Inazawa
Carcinogenesis 31 (5), 766-776, 2009
|Clinical heterogeneity of α‐synuclein gene duplication in Parkinson's disease|
K Nishioka, S Hayashi, MJ Farrer, AB Singleton, H Yoshino, H Imai, ...
Annals of Neurology: Official Journal of the American Neurological …, 2006
|PPM1D is a potential target for 17q gain in neuroblastoma|
F Saito-Ohara, I Imoto, J Inoue, H Hosoi, A Nakagawara, T Sugimoto, ...
Cancer research 63 (8), 1876-1883, 2003
|Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas|
I Imoto, ZQ Yang, A Pimkhaokham, H Tsuda, Y Shimada, M Imamura, ...
Cancer research 61 (18), 6629-6634, 2001
|Identification of a novel gene, GASC1, within an amplicon at 9p23–24 frequently detected in esophageal cancer cell lines|
ZQ Yang, I Imoto, Y Fukuda, A Pimkhaokham, Y Shimada, M Imamura, ...
Cancer research 60 (17), 4735-4739, 2000
|Alteration in copy numbers of genes as a mechanism for acquired drug resistance|
K Yasui, S Mihara, C Zhao, H Okamoto, F Saito-Ohara, A Tomida, ...
Cancer research 64 (4), 1403-1410, 2004
|The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer|
A Uesugi, K Kozaki, T Tsuruta, M Furuta, K Morita, I Imoto, K Omura, ...
Cancer research 71 (17), 5765-5778, 2011
|miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer|
T Tsuruta, K Kozaki, A Uesugi, M Furuta, A Hirasawa, I Imoto, N Susumu, ...
Cancer research 71 (20), 6450-6462, 2011
|Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets|
A Hirasawa, F Saito-Ohara, J Inoue, D Aoki, N Susumu, T Yokoyama, ...
Clinical Cancer Research 9 (6), 1995-2004, 2003
|History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trøndelag Health Study, Norway|
MM Iversen, GS Tell, T Riise, BR Hanestad, T Østbye, M Graue, ...
Diabetes care 32 (12), 2193-2199, 2009
|Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy|
I Imoto, H Tsuda, A Hirasawa, M Miura, M Sakamoto, S Hirohashi, ...
Cancer research 62 (17), 4860-4866, 2002
|YAP is a candidate oncogene for esophageal squamous cell carcinoma|
T Muramatsu, I Imoto, T Matsui, K Kozaki, S Haruki, M Sudol, Y Shimada, ...
Carcinogenesis 32 (3), 389-398, 2010
|TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas|
K Yasui, S Arii, C Zhao, I Imoto, M Ueda, H Nagai, M Emi, J Inazawa
Hepatology 35 (6), 1476-1484, 2002
|Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma|
S Komatsu, I Imoto, H Tsuda, K Kozaki, T Muramatsu, Y Shimada, S Aiko, ...
Carcinogenesis 30 (7), 1139-1146, 2009
|Genome‐wide array‐based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome|
P Loukopoulos, T Shibata, H Katoh, A Kokubu, M Sakamoto, K Yamazaki, ...
Cancer science 98 (3), 392-400, 2007
|Comparative genomic hybridization (CGH)‐arrays pave the way for identification of novel cancer‐related genes|
J Inazawa, J Inoue, I Imoto
Cancer science 95 (7), 559-563, 2004
|PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma|
K Kozaki, I Imoto, A Pimkhaokham, S Hasegawa, H Tsuda, K Omura, ...
Cancer science 97 (12), 1351-1358, 2006
|Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma|
I Sonoda, I Imoto, J Inoue, T Shibata, Y Shimada, K Chin, M Imamura, ...
Cancer research 64 (11), 3741-3747, 2004
|Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers|
S Honda, P Loher, M Shigematsu, JP Palazzo, R Suzuki, I Imoto, ...
Proceedings of the National Academy of Sciences 112 (29), E3816-E3825, 2015